Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
203.00    0.00 (0.00%)
Bid:
198.00
Ask:
203.00
Spread: 5.00 (2.525%)
Market Cap: £108.65m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Directorate Change

28 Feb 2017 07:00

RNS Number : 9679X
Microgen PLC
28 February 2017
 

28 February 2017

 



MICROGEN PLC

 

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Microgen Plc ("Microgen", or "the Company") is pleased to announce the appointment of Barbara Moorhouse as a non-executive director of the Company with effect from 1 April 2017.

 

Barbara has over 25 years of senior UK and international management experience in both operating and financial roles. She has spent the major part of her career in the private sector, including holding Chief Finance Officer positions with the listed international software companies Kewill Systems plc and Scala Solutions NV. Her recent executive roles have included Chief Operating Officer of Westminster City Council, Director General at the Ministry of Justice and subsequently at the Department for Transport.

 

Barbara is currently a non-executive director of IDOX plc, Agility Trains and the Lending Standards Board. She is a former chair of OPM Group. Barbara is also a Trustee and Chair of Audit Committee at Guys and St Thomas' Charity.

 

On her appointment to the Microgen Board, Barbara will become a member of the Company's audit committee, remuneration committee and nomination committee. Barbara will also take on the role of audit committee chair following the retirement of Peter Bertram, the current chairman of the audit committee, at the Company's AGM on 24 April 2017.

 

Ivan Martin, non-executive chairman of Microgen, commented: "We are very pleased to welcome Barbara onto the Microgen board. Her IT sector knowledge combined with insights from her extensive experience across both the private and public sectors will be invaluable as Microgen continues to expand."

Save for the directorship in IDOX plc, there are no matters requiring disclosure pursuant to paragraph 9.6.13R of The Listing Rules.

 

For further information, please contact:

 

Microgen Plc

Ivan Martin - Non-Executive Chairman

020 7496 8100

Peter Whiting - Senior Independent Director

Mark Heather - Company Secretary

 

FTI Consulting

Darius Alexander

020 3727 1063

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATRMATMBTTBLR
Date   Source Headline
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSGrant of awards under 2016 Performance Share Plan
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 202411:40 amRNSTotal Voting Rights
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 202410:07 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSInterim Results
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTrading Update and Notice of Results
12th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSFynapse contract win with major existing client
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSNotification of Major Holdings
18th Jun 20247:00 amRNSFynapse Investor Insights Session

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.